GSK-NKF100096

Study Sponsor: GSK

Study Title

A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Major depressive Disorder (MDD)

Medicine or Vaccine (generic name)

casopitant

Sponsor Identification Number

NKF100096

Trial Registry Identification Number(#'s)

NCT00413023 2004-004984-32

Medical Condition

Depressive Disorder, Major

Phase

Phase 2

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=NKF100096

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00413023

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-004984-32

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The raw data are included within the analysis-ready data for this study and are not provided separately.

Date Added to this Site

July 2014